Search Results - zachary+kaminsky

3 Results

Sort By:

A DNA methylation and genotype specific biomarker of suicide attempt

Novel Biomarkers for Predicting Suicide RiskJHU REF: [C12394]Invention Novelty: This invention provides DNA methylation-based biomarkers for predicting suicide risk. Value Proposition: Almost 30,000 people die of suicide each year in the United States, and 1 million people die worldwide. In the teenage population, it is the second leading cause of...

Published: 3/12/2026 | Inventor(s): Holly Wilcox, Zachary Kaminsky

Keywords(s): Biomarker, Clinical Diagnostics, CNS and Neurological Disorders, Disease Indication, Epigenetic, In Vitro Diagnostics, In Vitro Diagnostics (Old), Methylation, Prognostic Biomarker, Psychiatric Diseases, Suicidal Impulses, Suicide/Suicidal Impulses

Category(s): Clinical and Disease Specializations, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics > Prognostics Biomarkers, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Psychiatry, Clinical and Disease Specializations > Psychiatry > Suicidal Impulses

DNA Methylation Biomarkers of Post Partum Depression Risk

Invention Novelty: This invention provides DNA methylation-based biomarkers for predicting postpartum depression (PPD) risk . Value Proposition: PPD occurs in approximately 10-15% of women and represents a serious health risk to both mothers and their offspring. Increased depression risk in pregnant women is not predicted by hormonal fluctuations. This...

Published: 3/12/2026 | Inventor(s): Zachary Kaminsky, Jennifer Payne, Todd Gould

Keywords(s): Biomarker, Clinical Diagnostics, CNS and Neurological Disorders, Disease Indication, In Vitro Diagnostics, Post Partum Depression, Postpartum Depression, Prognostic Biomarker, Psychiatric Diseases

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Women's Health, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics > Prognostics Biomarkers, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Psychiatry, Clinical and Disease Specializations > Psychiatry > Postpartum Depression

MEpigenetic Biomarker-based Method for Predicting PTSD

Value PropositionEarly risk identification: Measuring DNA methylation at a specific SKA2 gene CpG site provides an objective biomarker for PTSD risk. Testing can occur pre-stressor (baseline susceptibility) or at both pre- and post-stressor time points (stress-induced changes), enabling risk identification before symptoms develop.Objective prediction...

Published: 3/12/2026 | Inventor(s): Zachary Kaminsky, Marco Boks

Keywords(s): Biomarker, Clinical Diagnostics, CNS and Neurological Disorders, Disease Indication, In Vitro Diagnostics, Post-Traumatic Stress Disorder, Post-Traumatic Stress Disorder (PTSD), Prognostic Biomarker, Psychiatric Diseases

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Psychiatry > Post-Traumatic Stress Disorder, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics > Prognostics Biomarkers, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Psychiatry